Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AbbVie
Scientific Title
A Phase 1/2 Study of ABT-199 in Combination With Low-Dose Cytarabine in Treatment-Naive Subjects With Acute Myelogenous Leukemia Who Are at Least 65 Years of Age and Who Are Not Eligible for Standard Anthracycline-Based Induction Therapy